SGMO

Sangamo Therapeutics Inc (SGMO)

US
$ 0.46-38.4%

Price Chart

Key Statistics

Market Cap
$ 117.84M
P/E Ratio
0.00
Revenue (TTM)
$ 63.76M
Volume
15.52M
52W High
$ 3.18
52W Low
$ 0.37
Dividend Yield
0.00%
Beta
1.21

Technicals

50-Day MA
0.5298
200-Day MA
1.1319
52 Week High
3.179
52 Week Low
0.3723

About SGMO

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases i.

Employees
183
Headquarters
Richmond, CA
CEO
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96